D. Newton

Superantigenic properties of the group A streptococcal exotoxin SpeF (MF)

A. Norrby-Teglund, M. Kotb, S. Holm, 1994, Infection and immunity.

Selective Depletion Of Vβ-Bearing T Cells In Patients With Severe Invasive Group A Streptococcal Infections And Streptococcal Toxic Shock Syndrome

B. Schwartz, M. Kotb, D. Low, 1995 .

Characterization of unique human TCR V beta specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein.

E. Sokurenko, J. Takahara, M. Kotb, 1994, Journal of immunology.

Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.

R. Kaul, U. Andersson, A. Norrby-Teglund, 1996, Journal of immunology.

Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.

M. Kotb, T. Kalland, M. Dohlsten, 1996, Journal of immunology.

Novel superantigens from streptococcal toxic shock syndrome Streptococcus pyogenes isolates.

A. Norrby-Teglund, M. Kotb, D. Low, 1997, Advances in experimental medicine and biology.

Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.

K. Lundin, M. Kotb, T. Kalland, 1996, Journal of immunology.

Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer.

L. Weiner, M. Kotb, R. Alpaugh, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.